Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans (Nature Communications (2015) 5 (4871) DOI 10.1038/ncomms5871);A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans

Nature Communications

Volumn 5, Issue , 2014, Pages

  Timpson, Nicholas J ^a,i   Walter, Klaudia ^b,m   Min, Josine L ^a,i   Tachmazidou, Ioanna ^b   Malerba, Giovanni ^c   Shin, So Youn ^a,i,m   Chen, Lu ^b,d,m   Futema, Marta ^e   Southam, Lorraine ^b,f,m   Iotchkova, Valentina ^b   Cocca, Massimiliano ^b   Huang, Jie ^b,m   Memari, Yasin ^b,m   McCarthy, Shane ^b,m   Danecek, Petr ^b,m   Muddyman, Dawn ^b,m   Mangino, Massimo ^g   Menni, Cristina ^g   Perry, John R B ^g,h   Ring, Susan M ^a,i   Gaye, Amadou ⁱ   Dedoussis, George ^j   Farmaki, Aliki Eleni ^j   Burton, Paul ⁱ   Talmud, Philippa J ^e   Gambaro, Giovanni ^k   Spector, Tim D ^g   Smith, George Davey ^a,i   Durbin, Richard ^b,m   Richards, J Brent ^g,l,w,ak,al   Humphries, Steve E ^e   Zeggini, Eleftheria ^b,m   Soranzo, Nicole ^b,d,m   Turki, Saeed Al ^m,n   Anderson, Carl ^m   Anney, Richard ^o   Antony, Dinu ^p   Artigas, Maria Soler ^q   Ayub, Muhammad ^r   Balasubramaniam, Senduran ^m   Barrett, Jeffrey C ^m   Barroso, Iněs ^m,s   Beales, Phil ^p   Bentham, Jamie ^f   Bhattacharya, Shoumo ^f   Birney, Ewan ^m   Blackwood, Douglas ^t   Bobrow, Martin ^u   Bochukova, Elena ^s   Bolton, Patrick ^g   Bounds, Rebecca ^s   Boustred, Chris ⁱ   Breen, Gerome ^g   Calissano, Mattia ^v   Carss, Keren ^m   Chatterjee, Krishna ^s   Ciampi, Antonio ^w   Cirak, Sebhattin ^v,x   Clapham, Peter ^m   Clement, Gail ^g   Coates, Guy ^m   Collier, David ^g,y   Cosgrove, Catherine ^f   Cox, Tony ^m   Craddock, Nick ^z   Crooks, Lucy ^m,aa   Curran, Sarah ^g,ab,ac   Curtis, David ^e   Daly, Allan ^m   Day Williams, Aaron ^m,ad   Day, Ian N M ⁱ   Down, Thomas ^m,ae   Du, Yuanping ^af   Dunham, Ian ^m   Edkins, Sarah ^m   Ellis, Peter ^m   Evans, David ^i,ag   Faroogi, Sadaf ^s   Fatemifar, Ghazaleh ⁱ   Fitzpatrick, David R ^ah   Flicek, Paul ^m   Flyod, James ^m,ai   Foley, A Reghan ^v   Franklin, Christopher S ^m   Gallagher, Louise ^o   Gaunt, Tom ⁱ   Geihs, Matthias ^m   Geschwind, Daniel ^aj   Greenwood, Celia ^w,ak,al   Griffin, Heather ^am   Grozeva, Detelina ^u   Guo, Xueqin ^af   Guo, Xiaosen ^af   Gurling, Hugh ^e   Hart, Deborah ^g   Hendricks, Audrey ^m,an   Holmans, Peter ^z   Howie, Bryan ^ao   Huang, Liren ^af   Hubbard, Tim ^m,ae   Hurles, Matthew E ^m   Hysi, Pirro ^g   Jackson, David K ^m   Jamshidi, Yalda ^ap   Jing, Tian ^af   Joyce, Chris ^m   Kaye, Jane ^am   Keane, Thomas ^m   Keogh, Julia ^s   Kemp, John ^i,ag   Kennedy, Karen ^m   Kolb Kokocinski, Anja ^m   Lachance, Genevieve ^g   Langford, Cordelia ^m   Lawson, Daniel ⁱ   Lee, Irene ^p   Lek, Monkol ^ar   Liang, Jieqin ^af   Lin, Hong ^af   Li, Rui ^ak,al   Li, Yingrui ^af   Liu, Ryan ^af   Lönnqvist, Jouko ^as   Lopes, Margarida ^f,m,at   Lotchkova, Valentina ^m   MacArthur, Daniel ^m,ar,at   Marchini, Jonathan ^am   Maslen, John ^m   Massimo, Mangino ^g   Mathieson, Iain ^au   Marenne, Gaëlle ^m   McGuffin, Peter ^g   McIntosh, Andrew ^t   McKechanie, Andrew G ^t,av   McQuillin, Andrew ^e   Metrustry, Sarah ^g   Mitchison, Hannah ^p   Moayyeri, Alireza ^g,aw   Morris, James ^m   Muntoni, Francesco ^v   Northstone, Kate ⁱ   O'Donnovan, Michael ^z   Onoufriadis, Alexandros ^ae   O'Rahilly, Stephen ^s   Oualkacha, Karim ^ax   Owen, Michael J ^z   Palotie, Aarno ^m,at,ay   Panoutsopoulou, Kalliope ^m   Parker, Victoria ^s   Parr, Jeremy R ^az   Paternoster, Lavinia ⁱ   Paunio, Tiina ^as,ay   Payne, Felicity ^m   Pietilainen, Olli ^m,as,ay   Plagnol, Vincent ^e   Quaye, Lydia ^g   Quail, Michael A ^m   Raymond, Lucy ^u   Rehnström, Karola ^m   Ritchie, Graham R S ^m   Roberts, Nicola ^u   Savage, David B ^s   Scambler, Peter ^p   Schiffels, Stephen ^m   Schmidts, Miriam ^p   Schoenmakers, Nadia ^s   Semple, Robert K ^s   Serra, Eva ^m   Sharp, Sally I ^e   Shihab, Hasheem ⁱ   Skuse, David ^p   Small, Kerrin ^g   Spasic Boskovic, Olivera ^u   Clair, David St ^ba   Stalker, Jim ^m   Stevens, Elizabeth ^v   Pourcian, Beate St ^a,i,bb   Sun, Jianping ^w,ak   Surdulescu, Gabriela ^g   Suvisaari, Jaana ^as   Tachmazidou, Ionna ^m   Tobin, Martin D ^m   Valdes, Ana ^g   Van Kogelenberg, Margriet ^m   Vijayarangakannan, Parthiban ^m   Visscher, Peter M ^ag   Wain, Louise V ^q   Walters, James T R ^z   Wang, Guangbiao ^af   Wang, Jun ^{af,aq,bc,bd,be}   Wang, Yu ^af   Ward, Kirsten ^g   Wheeler, Elanor ^m   Whyte, Tamieka ^v   Williams, Hywel ^z   Williamson, Kathleen A ^ah   Wilson, Crispian ^u   Wilson, Scott G ^g,bf,bg   Wong, Kim ^m   Xu, ChangJiang ^w,ak   Yang, Jian ^a,ag   Zhang, Fend ^g   Zhang, Pingbo ^af   Zheng, Hou Feng ^ak,al   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j HAROKOPIO UNIVERSITY   (Greece)

^k CATHOLIC UNIVERSITY   (Italy)

^l MCGILL UNIVERSITY   (Canada)

^m WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

ⁿ KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^o ST JAMES S HOSPITAL   (Ireland)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

^q UNIVERSITY OF LEICESTER   (United Kingdom)

^r QUEEN S UNIVERSITY   (Canada)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t UNIVERSITY OF EDINBURGH   (United Kingdom)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^w MCGILL UNIVERSITY   (Canada)

^x UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^y ELI LILLY AND COMPANY   (United States)

^z CARDIFF UNIVERSITY   (United Kingdom)

^aa SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^ab UNIVERSITY OF SUSSEX   (United Kingdom)

^ac SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^ad BIOGEN   (United States)

^ae KING'S COLLEGE LONDON   (United Kingdom)

^af BGI SHENZHEN   (China)

^ag UNIVERSITY OF QUEENSLAND   (Australia)

^ah WESTERN GENERAL HOSPITAL   (United Kingdom)

^ai UNIVERSITY OF LONDON   (United Kingdom)

^aj UNIVERSITY OF CALIFORNIA   (United States)

^ak MCGILL UNIVERSITY   (Canada)

^al MCGILL UNIVERSITY   (Canada)

^am UNIVERSITY OF OXFORD   (United Kingdom)

^an UNIVERSITY OF COLORADO   (United States)

^ao ADAPTIVE BIOTECHNOLOGIES   (United States)

^ap ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^aq UNIVERSITY OF HONG KONG   (Hong Kong)

^ar MASSACHUSETTS GENERAL HOSPITAL   (United States)

^as NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^at BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^au HARVARD MEDICAL SCHOOL   (United States)

^av UNIVERSITY OF EDINBURGH   (United Kingdom)

^aw IMPERIAL COLLEGE LONDON   (United Kingdom)

^ax UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^ay UNIVERSITY OF HELSINKI   (Finland)

^az NEWCASTLE UNIVERSITY   (United Kingdom)

^ba UNIVERSITY OF ABERDEEN   (United Kingdom)

^bb UNIVERSITY OF BRISTOL   (United Kingdom)

^bc UNIVERSITY OF COPENHAGEN   (Denmark)

^bd KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^be MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^bf UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^bg SIR CHARLES GAIRDNER HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALLELE; GENETIC VARIATION; LIPID; NUCLEIC ACID ANALYSIS; PLASMA; PROTEIN;

ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORTHERN EUROPEAN; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN EUROPEAN; TRIACYLGLYCEROL BLOOD LEVEL; ALLELE; ALTERNATIVE RNA SPLICING; BLOOD; CAUCASIAN; CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; MULTICENTER STUDY; TWINS;

ALLELES; ALTERNATIVE SPLICING; APOLIPOPROTEIN C-III; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES; TWINS;

EID: 84923648340     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8171     Document Type: Erratum

References (60)

1. Arsenault, B. J., Boekholdt, S. M. & Kastelein, J. J. Lipid parameters for measuring risk of cardiovascular disease. Nat. Rev. Cardiol. 8, 197-206 (2011
2. Global Lipids Genetics, C. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013
3. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010
4. Weiss, L. A., Pan, L., Abney, M. & Ober, C. The sex-specific genetic architecture of quantitative traits in humans. Nat. Genet. 38, 218-222 (2006
5. Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl Acad. Sci. 109, 1193-1198 (2012
6. Johansen, C. T. et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 42, 684-687 (2010
7. Cohen, J. et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science (New York, NY) 305, 869-872 (2004
8. Stitziel, N. O. et al. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 33, 2909-2914 (2013
9. Lange, L. A. et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233-245 (2014
10. Peloso, Gina M. et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 Whites and Blacks. Am. J. Hum. Genet. 94, 223-232 (2014
11. Holmen, O. L. et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345-351 (2014
12. Goldstein, D. B. et al. Sequencing studies in human genetics: design and interpretation. Nat. Rev. Genet. 14, 460-470 (2013
13. Kotowski, I. K. et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am. J. Hum. Genet. 78, 410-422 (2006
14. Moayyeri, A., Hammond, C. J., Valdes, A. M. & Spector, T. D. Cohort Profile: TwinsUK and healthy ageing twin study. Int. J. Epidemiol. 42, 76-85 (2013
15. Boyd, A. et al. Cohort Profile: the 'children of the 90s'-the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 42, 111-127 (2013
16. Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82-93 (2011
17. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007
18. Karathanasis, S. K. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc. Natl Acad. Sci. USA 82, 6374-6378 (1985
19. Reue, K., Leff, T. & Breslow, J. L. Human apolipoprotein CIII gene expression is regulated by positive and negative cis-Acting elements and tissue-specific protein factors. J. Biol. Chem. 263, 6857-6864 (1988
20. Ogami, K., Hadzopoulou-Cladaras, M., Cladaras, C. & Zannis, V. I. Promoter elements and factors required for hepatic and intestinal transcription of the human ApoCIII gene. J. Biol. Chem. 265, 9808-9815 (1990
21. Vergnes, L., Taniguchi, T., Omori, K., Zakin, M. M. & Ochoa, A. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers. Biochim. Biophys. Acta. 1348, 299-310 (1997
22. Carlson, L. A. & Ballantyne, D. Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia. Atherosclerosis 23, 563-568 (1976
23. Malmendier, C. L. et al. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis 77, 139-149 (1989
24. Aalto-Setala, K. et al. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice. J. Lipid Res. 37, 1802-1811 (1996
25. Ebara, T., Ramakrishnan, R., Steiner, G. & Shachter, N. S. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J. Clin. Invest. 99, 2672-2681 (1997
26. Dallinga-Thie, G. M. et al. Complex genetic contribution of the Apo AI-CIIIAIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. J. Clin. Invest. 99, 953-961 (1997
27. Dallinga-Thie, G. M. et al. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37, 136-147 (1996
28. Ribalta, J. et al. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia. J. Lipid Res. 38, 1061-1069 (1997
29. Tachmazidou, I. et al. A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nat. Commun. 4, 2872 (2013
30. Pollin, T. I. et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702-1705 (2008
31. Yeo, G. & Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377-394 (2004
32. Consortium, G. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585 (2013
33. Siepel, A. et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15, 1034-1050 (2005
34. Varbo, A., Benn, M. & Nordestgaard, B. G. Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol. Ther. 141, 358-367 (2014
35. Hokanson, J. E. & Austin, M. A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-Analysis of population-based prospective studies. J. Cardiovasc. Risk 3, 213-219 (1996
36. Yarnell, J. W. et al. Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts. Arterioscler. Thromb. Vasc. Biol. 21, 1340-1345 (2001
37. Varbo, A., Benn, M., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation 128, 1298-1309 (2013
38. Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352 (2013
39. The Emerging Risk Factors, C. MAjor lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993-2000 (2009
40. Visser, M. E., Witztum, J. L., Stroes, E. S. & Kastelein, J. J. Antisense oligonucleotides for the treatment of dyslipidaemia. Eur. Heart. J. 33, 1451-1458 (2012
41. Davey Smith, G. & Ebrahim, S. Mendelian randomization: prospects, potentials, and limitations. Int. J. Epidemiol. 33, 30-42 (2004
42. Williams, D. M. et al. Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children. Heart. 99, 1849-1856 (2013
43. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972
44. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010
45. Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987-2993 (2011
46. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011
47. Browning, S. R. & Browning, B. L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084-1097 (2007
48. International HapMap, C. et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52-58 (2010
49. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006
50. O'Connell, J. et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 10, e1004234 (2014
51. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009
52. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-Assembling DNA nanoarrays. Science 327, 78-81 (2010
53. Williams, F. M. et al. Genes contributing to pain sensitivity in the normal population: an exome sequencing study. PLoS Genet. 8, e1003095 (2012
54. Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499-511 (2010
55. Zhou, X. & Stephens, M. Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44, 821-824 (2012
56. Magi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-Analysis. BMC Bioinformatics 11, 288 (2010
57. Purcell, S. et al. PLINK: A tool for whole-genome association and populationbased linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007
58. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76-82 (2011
59. Voight, B. F. et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572-580 (2012
60. Protter, A. A. et al. Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes. DNA 3, 449-456 (1984).